EFPIA：2024年欧洲生命科学竞争力战略报告（英文版）

The life sciences sector is one of Europe’s most important strategic assets, delivering innovative medicines and vaccines that are fundamental to the long-term health and security of EU citizens. In recent decades we have seen HIV turned from a death sentence to a condition that can be managed, huge advances in cancer care transforming survival rates, hepatitis C can now be cured in 95% of patients, and there are new tools to stem the tide of the obesity epidemic and manage cardio-vascular di